Swissmedic launches the public consultation on Guideline M14 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH Guidelines), with a deadline of 30 August 2024 for comments
Anpassung der Rubriken Dosierung, Wartezeit(en), besondere Warnhinweise für die Zieltierart und Nebenwirkungen für Procain-Penicillin-haltige Tierarzneimittel
Swissmedic monitors all therapeutic products on the market in Switzerland. Our independent experts ensure the therapeutic products you and your loved ones need are effective, safe and of the highest quality.
Reporting of ADRs by healthcare professionals
Find out in the video how to report adverse drug reactions properly.
Materiovigilance – every report counts!
Serious incidents involving medical devices: find out in the video why every report counts!
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
